Cerebral Palsy (CP)
Conditions
Brief summary
This observational pilot study will include 40 children and adolescents aged 6 to 12 years: 20 with cerebral palsy and 20 with typical development. The main purpose is to determine whether Pupil Labs Neon wearable eye-tracking glasses can be used reliably while participants perform structured tasks using both hands. Each participant will attend one study visit. After assessments of near vision, hand function, visual perception, visual-motor function, and attention-related characteristics, participants will wear the eye-tracking glasses. They will view an instruction card, find target objects, and place the objects into boxes using both hands. The tasks will be completed under three conditions that vary visual-search and sequencing demands, with breaks provided as needed. Researchers will evaluate whether the planned procedures can be completed and whether the recordings provide usable eye-tracking data. Exploratory analyses will examine how gaze and hand actions are coordinated and whether these patterns differ between the cerebral palsy and typical-development groups or across task conditions. No treatment will be provided, and the study is not designed to evaluate treatment effectiveness. The findings will be used to improve the measurement protocol and quality-control procedures for future research.
Interventions
OTHERWearable Eye-Tracking Assessment During Structured Bimanual Tasks
Participants wear the Pupil Neon eye-tracking system during one study visit while performing structured visual-search and goal-directed bimanual tasks under a standard condition, an increased visual-search-demand condition, and an increased sequencing-demand condition. The order of conditions is counterbalanced. The system records two-dimensional gaze coordinates and egocentric scene video to evaluate protocol feasibility, data quality, and exploratory gaze-behavior measures. The assessment is research-specific and does not provide treatment, rehabilitation training, visual cues, stimulation, or performance feedback and does not alter clinical care.
Sponsors
Samsung Medical Center
National Research Foundation of Korea
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Intervention model description
Participants are enrolled into one of two parallel groups based on pre-existing clinical status: unilateral cerebral palsy or typical development. Both groups complete the same single-visit wearable eye-tracking and structured bimanual task-assessment protocol. Group assignment is non-randomized; no therapeutic treatment is assigned. The order of the three task conditions is counterbalanced within each participant.
Eligibility
Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No
Inclusion criteria
General Inclusion Criteria Children aged 6-12 years * Ability to understand simple instructions required for the study procedures and perform structured visual and bimanual tasks * For children who routinely wear glasses or contact lenses, ability to view near visual stimuli and task materials with their habitual vision correction * Written informed consent provided by a parent or legally authorized representative, with the child providing assent after receiving an age- and developmentally appropriate explanation of the study Cerebral Palsy Group * Diagnosis of cerebral palsy confirmed by a pediatric physiatrist * Manual Ability Classification System (MACS) level I-III * Ability to grasp or manipulate task materials with at least one hand and attempt bimanual task performance Typically Developing Group * Typical developmental history based on parent report and confirmation by the research team * No history of neurological disorders, including cerebral palsy, or musculoskeletal conditions affecting upper-limb function * No diagnosis of a neurodevelopmental disorder that may affect task performance, such as attention-deficit/hyperactivity disorder, autism spectrum disorder, or intellectual disability
Exclusion criteria
* Visual impairment that prevents the child from adequately viewing near visual stimuli or task materials, even with habitual vision correction * Severe strabismus, nystagmus, or another ophthalmologic condition judged likely to substantially compromise stable eye-tracking data collection * Severe cognitive, communication, or behavioral difficulties that prevent adequate understanding or performance of the study tasks * Severe upper-limb joint contracture, pain, fracture, or another musculoskeletal condition that prevents safe performance of the bimanual tasks * Uncontrolled epilepsy, acute illness, unstable medical condition, or any other condition judged to make study participation unsafe
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Successful Gaze-Position Verification Rate | Day 1, before structured task recording | Percentage of participants for whom gaze position is successfully verified at predefined central and task-relevant locations before task recording, after offset correction when needed. The rate will be calculated as the number with successful verification divided by the number attempting eye-tracker setup, multiplied by 100. Reasons for unsuccessful verification will be recorded. |
| Wearable Eye-Tracking Protocol Completion Rates | Day 1, during the single study visit (up to 180 minutes) | Three completion percentages will be calculated separately: (1) participants successfully fitted with the Pupil Neon and starting recording divided by all enrolled participants; (2) participants completing all three planned task conditions divided by those starting the wearable eye-tracking assessment; and (3) participants completing each condition divided by those scheduled for that condition. Each value will be multiplied by 100. Reasons for noncompletion will be categorized. |
| Mean Valid Gaze Data Proportion | Day 1, during the structured eye-tracking task assessment (up to 180 minutes) | Percentage of sampled time points within each predefined analysis interval for which a valid two-dimensional gaze coordinate is available. Values range from 0 to 100, with higher values indicating more complete gaze data. Results will be summarized by task condition and study group. Trials with less than 70 percent valid gaze data will be flagged for quality control but retained in the feasibility denominator. |
| Analyzable Eye-Tracking Trial Rate | Day 1, during the structured eye-tracking task assessment (up to 180 minutes) | Percentage of attempted trials with synchronized scene video, gaze coordinates, and task-event annotations sufficient to derive the predefined area-of-interest and event measures. The rate will be calculated as the number of analyzable trials divided by all attempted trials, multiplied by 100. Reasons for non-analyzability will be categorized as device slippage, field-of-view occlusion, lighting problems, signal loss, missing data streams, synchronization failure, or other. |
| Mean Total Study Assessment Duration | Day 1, from initiation of the first study assessment through completion or discontinuation of the final planned assessment (up to 180 minutes) | Elapsed time in minutes from initiation of the first study assessment after consent to completion or discontinuation of the final planned assessment, including rest breaks. Duration will be summarized separately for each study group. |
| Number of Participants With Assessment-Related Discomfort or Protocol Interruption | Day 1, from the start of the study visit through the immediate post-assessment period (up to 180 minutes) | Number and percentage of participants experiencing fatigue, eye strain, pressure from the eye-tracking glasses, headache, dizziness, upper-limb fatigue, distress or refusal, or other discomfort, and participants requiring a pause, device adjustment, or early discontinuation. Events will be summarized by type, severity, action taken, and resolution. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mean Overall and Phase-Specific Task Performance Time | Day 1, during the structured eye-tracking task assessment (up to 180 minutes) | Mean time in seconds from task onset to task completion and for the predefined phases of instruction-card viewing, visual search, object selection, transport, insertion, and phase transition. Each timing measure will be reported separately by task condition and study group. |
| Mean Number of Task Errors and Instruction-Card Rechecks per Trial | Day 1, during the structured eye-tracking task assessment (up to 180 minutes) | Mean number per trial of incorrect object selections, sequence errors, and returns to the instruction card. Each event type will be reported separately by task condition and study group. Higher counts indicate more frequent task-performance disruptions. |
| Mean Time to First Target Fixation | Day 1, during the structured eye-tracking task assessment (up to 180 minutes) | Mean time in seconds from the trial-start event to the onset of the first valid fixation within the target area of interest. Longer times indicate slower visual identification of the target. |
| Mean Area-of-Interest-Specific Fixation-Time Proportion | Day 1, during the structured eye-tracking task assessment (up to 180 minutes) | Percentage of total valid fixation duration within the analysis interval allocated to each predefined area of interest, including the target, non-target items, and distractors. Each area-of-interest proportion will be reported separately by task condition and study group. |
Countries
South Korea
Contacts
CONTACTYoungsub Hwang, PhD
PRINCIPAL_INVESTIGATORJeong-Yi Kwon, PhD
Samsung Medical Center
Outcome results
None listed